List of works - Ursula Muñoz

A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.

scientific article published on January 2013

Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients.

scientific article

Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].

scientific article published on 15 June 2012

Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome

scientific article

Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients.

scientific article published on May 2005

An experimental model of partial insulin-like growth factor-1 deficiency in mice

scientific article published on 18 September 2013

Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency.

scientific article published on 4 May 2017

GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21 ⬇️

scientific article published on October 22, 2012

Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease ⬇️

scientific article published on March 1, 2012

Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.

scientific article published on 2 August 2012

IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.

scientific article

Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy.

scientific article

On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.

scientific article published in November 2008

Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy

scientific article published in January 2016

Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins

scientific article published on 14 August 2017

Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis ⬇️

scientific article published on January 23, 2013

Serum antibodies to phosphatidylcholine in MS

scientific article published on 09 June 2020

The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients.

scientific article

The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy

scientific article

List of works by Ursula Muñoz

A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.

Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients.

Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].

Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome

Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients.

An experimental model of partial insulin-like growth factor-1 deficiency in mice

Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency.

GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21 ⬇️

Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease ⬇️

Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.

IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.

Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy.

On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.

Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy

Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins

Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis ⬇️

Serum antibodies to phosphatidylcholine in MS

The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients.

The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy